Meg Byrne

Meg Byrne has extensive work experience in the field of cellular engineering and gene editing. Meg currently works at bit.bio as a Group Leader in Cellular Engineering since November 2022. Prior to this, they held the position of Senior Scientist and Cell Engineering Lead at bit.bio from April 2021 to November 2022. In these roles, they led a team that utilized gene editing technologies to generate pluripotent stem cell lines with inducible capabilities for differentiation and also worked on generating reporter cell lines and disease models.

Before joining bit.bio, Meg worked at the Wellcome Sanger Institute from October 2016 to April 2021 as a Gene Editing Senior Research Assistant. Their responsibilities included using CRISPR and other gene editing technologies to edit the genomes of various cell types, including SNPs, knock-outs, knock-ins, barcoding, and tagging. Prior to this, they worked as a Scientist at the Wellcome Sanger Institute in 2012.

Meg's earlier work experience includes a role as a Post Doctoral Scientist and Associate Teacher at the University of Bristol from September 2009 to September 2012. Meg also pursued an EngD in Regenerative Medicine at UCL from September 2005 to August 2009. Additionally, they worked as an Industrial Placement Student at the National Institute for Biological Standards and Control (NIBSC) from July 2003 to August 2004. In this role, they focused on the optimization of an opsonophagocytic killing assay for screening patient sera after a novel vaccination.

Overall, Meg Byrne has built a strong background in cellular engineering, gene editing, and regenerative medicine throughout their career.

Meg Byrne attended The University of Manchester from 2001 to 2005, where they studied Biology with Industrial Experience. Their degree focused on Biology/Biological Sciences, General. In 2022, Meg obtained two additional certifications, "Articulating Your Value" and "Prevent Toxic Work Cultures as a Manager," both from LinkedIn.